vs

Side-by-side financial comparison of DigitalBridge Group, Inc. (DBRG) and MEDIFAST INC (MED). Click either name above to swap in a different company.

DigitalBridge Group, Inc. is the larger business by last-quarter revenue ($105.7M vs $75.1M, roughly 1.4× MEDIFAST INC). On growth, DigitalBridge Group, Inc. posted the faster year-over-year revenue change (4.1% vs -36.9%). DigitalBridge Group, Inc. produced more free cash flow last quarter ($258.0M vs $-6.6M). Over the past eight quarters, DigitalBridge Group, Inc.'s revenue compounded faster (19.2% CAGR vs -34.4%).

DigitalBridge Group, Inc. is a global digital infrastructure investment firm. The company owns, invests in and operates businesses such as cell towers, data centers, fiber, small cells, and edge infrastructure. Headquartered in Boca Raton, DigitalBridge has offices in Los Angeles, New York, Denver, London, and Singapore. As of June 2025, DigitalBridge had US$106 billion of assets under management.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

DBRG vs MED — Head-to-Head

Bigger by revenue
DBRG
DBRG
1.4× larger
DBRG
$105.7M
$75.1M
MED
Growing faster (revenue YoY)
DBRG
DBRG
+41.0% gap
DBRG
4.1%
-36.9%
MED
More free cash flow
DBRG
DBRG
$264.6M more FCF
DBRG
$258.0M
$-6.6M
MED
Faster 2-yr revenue CAGR
DBRG
DBRG
Annualised
DBRG
19.2%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DBRG
DBRG
MED
MED
Revenue
$105.7M
$75.1M
Net Profit
$65.1M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
61.5%
Revenue YoY
4.1%
-36.9%
Net Profit YoY
EPS (diluted)
$0.28
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBRG
DBRG
MED
MED
Q4 25
$105.7M
$75.1M
Q3 25
$93.3M
$89.4M
Q2 25
$85.3M
$105.6M
Q1 25
$90.1M
$115.7M
Q4 24
$101.6M
$119.0M
Q3 24
$76.6M
$140.2M
Q2 24
$390.3M
$168.6M
Q1 24
$74.4M
$174.7M
Net Profit
DBRG
DBRG
MED
MED
Q4 25
$65.1M
Q3 25
$31.4M
$-2.3M
Q2 25
$31.6M
$2.5M
Q1 25
$13.8M
$-772.0K
Q4 24
Q3 24
$13.8M
$1.1M
Q2 24
$91.4M
$-8.2M
Q1 24
$-29.6M
$8.3M
Gross Margin
DBRG
DBRG
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
DBRG
DBRG
MED
MED
Q4 25
-10.4%
Q3 25
-13.9%
-4.6%
Q2 25
-31.2%
-1.0%
Q1 25
-11.5%
-1.1%
Q4 24
5.7%
0.6%
Q3 24
62.4%
1.5%
Q2 24
33.5%
-4.7%
Q1 24
-20.7%
4.5%
Net Margin
DBRG
DBRG
MED
MED
Q4 25
61.5%
Q3 25
33.7%
-2.5%
Q2 25
37.1%
2.3%
Q1 25
15.3%
-0.7%
Q4 24
Q3 24
18.0%
0.8%
Q2 24
23.4%
-4.8%
Q1 24
-39.8%
4.8%
EPS (diluted)
DBRG
DBRG
MED
MED
Q4 25
$0.28
$-1.64
Q3 25
$0.09
$-0.21
Q2 25
$0.10
$0.22
Q1 25
$-0.01
$-0.07
Q4 24
$0.08
Q3 24
$-0.01
$0.10
Q2 24
$0.44
$-0.75
Q1 24
$-0.28
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBRG
DBRG
MED
MED
Cash + ST InvestmentsLiquidity on hand
$382.5M
$167.3M
Total DebtLower is stronger
$298.8M
Stockholders' EquityBook value
$2.1B
$198.9M
Total Assets
$3.4B
$248.0M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBRG
DBRG
MED
MED
Q4 25
$382.5M
$167.3M
Q3 25
$358.4M
$173.5M
Q2 25
$340.7M
$162.7M
Q1 25
$349.9M
$164.6M
Q4 24
$302.2M
$162.3M
Q3 24
$294.4M
$170.0M
Q2 24
$261.2M
$163.5M
Q1 24
$247.4M
$156.4M
Total Debt
DBRG
DBRG
MED
MED
Q4 25
$298.8M
Q3 25
$327.9M
Q2 25
$298.0M
Q1 25
$296.9M
Q4 24
$296.4M
Q3 24
$295.8M
Q2 24
$295.3M
Q1 24
$366.5M
Stockholders' Equity
DBRG
DBRG
MED
MED
Q4 25
$2.1B
$198.9M
Q3 25
$2.1B
$214.7M
Q2 25
$2.0B
$216.0M
Q1 25
$2.0B
$211.0M
Q4 24
$2.0B
$210.1M
Q3 24
$2.0B
$207.3M
Q2 24
$2.0B
$205.3M
Q1 24
$1.8B
$211.0M
Total Assets
DBRG
DBRG
MED
MED
Q4 25
$3.4B
$248.0M
Q3 25
$3.5B
$268.2M
Q2 25
$3.4B
$269.3M
Q1 25
$3.4B
$280.0M
Q4 24
$3.5B
$284.2M
Q3 24
$3.5B
$291.2M
Q2 24
$3.5B
$293.5M
Q1 24
$3.5B
$302.8M
Debt / Equity
DBRG
DBRG
MED
MED
Q4 25
0.14×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBRG
DBRG
MED
MED
Operating Cash FlowLast quarter
$259.3M
$-5.3M
Free Cash FlowOCF − Capex
$258.0M
$-6.6M
FCF MarginFCF / Revenue
244.0%
-8.8%
Capex IntensityCapex / Revenue
1.3%
1.8%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$440.5M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBRG
DBRG
MED
MED
Q4 25
$259.3M
$-5.3M
Q3 25
$56.5M
$12.1M
Q2 25
$77.0M
$-3.4M
Q1 25
$50.3M
$3.4M
Q4 24
$60.1M
$-4.9M
Q3 24
$35.9M
$9.1M
Q2 24
$22.5M
$13.1M
Q1 24
$-27.0M
$7.3M
Free Cash Flow
DBRG
DBRG
MED
MED
Q4 25
$258.0M
$-6.6M
Q3 25
$56.1M
$10.8M
Q2 25
$76.4M
$-4.8M
Q1 25
$50.0M
$1.9M
Q4 24
$56.5M
$-7.2M
Q3 24
$7.7M
Q2 24
$22.3M
$11.1M
Q1 24
$-30.1M
$5.4M
FCF Margin
DBRG
DBRG
MED
MED
Q4 25
244.0%
-8.8%
Q3 25
60.2%
12.0%
Q2 25
89.5%
-4.5%
Q1 25
55.5%
1.6%
Q4 24
55.7%
-6.1%
Q3 24
5.5%
Q2 24
5.7%
6.6%
Q1 24
-40.4%
3.1%
Capex Intensity
DBRG
DBRG
MED
MED
Q4 25
1.3%
1.8%
Q3 25
0.4%
1.5%
Q2 25
0.7%
1.3%
Q1 25
0.3%
1.3%
Q4 24
3.5%
1.9%
Q3 24
0.0%
1.0%
Q2 24
0.1%
1.1%
Q1 24
4.1%
1.1%
Cash Conversion
DBRG
DBRG
MED
MED
Q4 25
3.99×
Q3 25
1.80×
Q2 25
2.43×
-1.36×
Q1 25
3.65×
Q4 24
Q3 24
2.61×
8.04×
Q2 24
0.25×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons